Strategies for success: A PDSA analysis of three QI initiatives in critical care

Joint Commission Journal on Quality and Patient Safety

Volumn 34, Issue 8, 2008, Pages 435-444

  Lipshutz, Angela K M ^a,b   Fee, Christopher ^a   Schell, Hildy ^c   Campbell, Lundy ^d   Taylor, John ^e   Sharpe, Bradley A ^f   Nguyen, Jinhee ^g,h   Gropper, Michael A ^a,e,i  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c School of Nursing

^d Departments of Anesthesia and Perioperative Care Critical Care Medicine

^e Departments of Anesthesia and Perioperative Care/Critical Care Medicine ^*

^f Department of Medicine

^g UCSF School of Nursing

^h Glendale Adventist Medical Center   (United States)

ⁱ Critical Care Medicine

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; EVIDENCE BASED MEDICINE; GLYCEMIC INDEX; HEALTH CARE QUALITY; HUMAN; INTENSIVE CARE; INTERDISCIPLINARY COMMUNICATION; METHODOLOGY; RETROSPECTIVE STUDY; STANDARD; UNITED STATES;

CRITICAL CARE; EVIDENCE-BASED MEDICINE; GLYCEMIC INDEX; HUMANS; INTERDISCIPLINARY COMMUNICATION; QUALITY ASSURANCE, HEALTH CARE; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; SAN FRANCISCO;

EID: 50949132287     PISSN: 15537250     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1553-7250(08)34054-9     Document Type: Article

References (33)

1. Institute of Medicine: To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press, 2000.
2. McGlynn E.A., et al.: The quality of health care delivered to adults in the United States. N Engl J Med 348:2635-2645, Jun. 26, 2003.
3. Institute for Healthcare Improvement: Campaign. http://www.ihi.org/IHI/ Programs/Campaign/ (last accessed Jun. 11, 2008).
4. Resar R., et al.: Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf 31:243-248, May 2005.
5. Van den Berghe G., et al.: Insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367, Nov. 8, 2001.
6. Rivers E., et al.: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377, Nov. 8, 2001.
7. Rello J., et al.: Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest 100:439-444, Aug. 1991.
8. Safdar N., et al.: Clinical and economic consequences of ventilator-associated pneumonia: A systematic review. Crit Care Med 33:2184-2193, Oct. 2005.
9. Warren D.K., et al.: Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 31:1312-1317, May 2003.
10. Drakulovic M.B., et al.: Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: A randomised trial. Lancet 354:1851-1858, Nov. 1999.
11. Wittbrodt E.T.: Daily interruption of continuous sedation. Pharmacotherapy 25:3S-7S, May 2005.
12. Cook D., et al.: Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. Crit Care Med 27:2812-2817, Dec. 1999.
13. Attia J., et al.: Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med 161:1268-1279, May 2001.
14. Van den Berghe G., et al.: Intensive insulin therapy in the medical ICU. N Engl J Med 354:449-461, Feb. 2, 2006.
15. Van den Berghe G., et al.: Intensive insulin therapy in mixed medical/surgical intensive care units: Benefit versus harm. Diabetes 55:3151-3159, Nov. 2006.
16. Vriesendorp T.M., et al.: Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med 34:2714-2718, Nov. 2006.
17. Osborn T.M., Nguyen H.B., Rivers E.P.: Emergency medicine and the Surviving Sepsis campaign: An international approach to managing severe sepsis and septic shock. Ann Emerg Med 46:228-231, Oct. 2005.
18. Oba Y., Salzman G.A.: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 342:1301-1308, May 4, 2000.
19. Annane D., et al.: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862-871, Aug. 21, 2002.
20. Bernard G.R., et al.: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699-709, Mar. 8, 2001.
21. Dellinger R.P., et al.: Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858-873, Mar. 2004.
22. Krinsley J.S., Jones R.L.: Cost analysis of intensive glycemic control in critically ill adult patients. Chest 129:644-650, Mar. 2006.
23. Otero R.M., et al.: Early goal-directed therapy in severe sepsis and septic shock revisited: Concepts, controversies, and contemporary findings. Chest 130:1579-1595, Nov. 2006.
24. Angus D.C., et al.: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310, Jul. 2001.
25. Gropper M.A.: Evidence-based management of critically ill patients: Analysis and implementation. Anesth Analg 99:566-572, May 2006.
26. ClinicalTrials.gov: Glucontrol Study: Comparing the Effects of Two Glucose Control Regimens by Insulin in Intensive Care Unit Patients. National Institutes of Health. http://clinicaltrials.gov/ct2/show/NCT00107601? term=glucontrol&rank=1 (last accessed Jun. 12, 2008).
27. Brunkhorst F.M., et al.: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125-139, Jan. 10, 2008.
28. Loma Linda University Medical Center Department of Emergency Medicine: The STOP Sepsis Bundle Toolkit. http://lomalindahealth.org/services/ emergency/for-health-professionals/fellowships/patient-care/ (last accessed Jun. 13, 2008).
29. Beth Israel Deaconess Medical Center: The MUST Guide to Sepsis. http://sepsis.bidmc.harvard.edu/Content/start_frameset.htm (last accessed Jun. 11, 2008).
30. Bone R.C., et al.: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655, Jun. 1992.
31. Pronovost P.J., Miller M.R., Wachter R.M.: Tracking progress in patient safety: An elusive target. JAMA 296:696-699, Aug. 9, 2006.
32. Marti-Carvajal A., Salanti G., Cardona A.F.: Human recombinant activated protein C for severe sepsis. Cochrane Database Syst Rev 1:CD004388, Jan. 2008.
33. Sprung C.L., et al.: Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111-124, Jan. 10, 2008.